Collaboration IP. Ownership of Collaboration IP shall follow inventorship. Inventorship will be determined according to United States Patent Law (without reference to any conflict of law principles). Amgen, on behalf of itself and its Affiliates, hereby grants and agrees to grant to Kite a fully paid up, perpetual, worldwide, non-exclusive license, with a right to grant sublicenses, under Collaboration IP solely owned by it, solely to the extent such Collaboration IP claims an Improvement to Kite Platform Technology, to Exploit such Improvement to Kite Platform Technology for all purposes.
Appears in 2 contracts
Sources: Research Collaboration and License Agreement (Kite Pharma, Inc.), Research Collaboration and License Agreement (Kite Pharma, Inc.)